Snowden Capital Advisors’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $492K | Sell |
5,636
-2,337
| -29% | -$204K | 0.01% | 773 |
|
|
2025
Q1 | $544K | Sell |
7,973
-197
| -2% | -$13.5K | 0.02% | 702 |
|
|
2024
Q4 | $635K | Buy |
8,170
+1,548
| +23% | +$120K | 0.02% | 672 |
|
|
2024
Q3 | $444K | Sell |
6,622
-1,215
| -16% | -$81.5K | 0.01% | 824 |
|
|
2024
Q2 | $889K | Buy |
7,837
+466
| +6% | +$52.8K | 0.03% | 542 |
|
|
2024
Q1 | $1.02M | Buy |
7,371
+1,803
| +32% | +$250K | 0.03% | 498 |
|
|
2023
Q4 | $691K | Buy |
5,568
+471
| +9% | +$58.4K | 0.03% | 553 |
|
|
2023
Q3 | $476K | Sell |
5,097
-1,978
| -28% | -$185K | 0.02% | 678 |
|
|
2023
Q2 | $909K | Sell |
7,075
-413
| -6% | -$53.1K | 0.03% | 485 |
|
|
2023
Q1 | $870K | Sell |
7,488
-1,257
| -14% | -$146K | 0.03% | 494 |
|
|
2022
Q4 | $990K | Buy |
8,745
+1,796
| +26% | +$203K | 0.04% | 451 |
|
|
2022
Q3 | $559K | Buy |
6,949
+63
| +0.9% | +$5.07K | 0.03% | 606 |
|
|
2022
Q2 | $513K | Buy |
6,886
+3,322
| +93% | +$247K | 0.02% | 618 |
|
|
2022
Q1 | $455K | Buy |
3,564
+3,352
| +1,581% | +$428K | 0.02% | 661 |
|
|
2021
Q4 | $28K | Sell |
212
-2,136
| -91% | -$282K | ﹤0.01% | 1204 |
|
|
2021
Q3 | $321K | Buy |
2,348
+8
| +0.3% | +$1.09K | 0.02% | 665 |
|
|
2021
Q2 | $250K | Buy |
+2,340
| New | +$250K | 0.01% | 771 |
|